Gain Therapeutics
(NASDAQ) GANX
Gain Therapeutics Financials at a Glance
Market Cap
$70.39M
Revenue (TTM)
$0.00
Net Income (TTM)
$20.16M
EPS (TTM)
$-0.61
P/E Ratio
-2.98
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$1.82
Volume
10,828
Open
$1.89
Price
$1.82
Volume
10,828
Open
$1.89
Previous Close
$1.82
Daily Range
$1.76 - $1.92
52-Week Range
$1.41 - $4.34
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$1.82
Volume
10,828
Open
$1.89
Previous Close
$1.82
Daily Range
$1.76 - $1.92
52-Week Range
$1.41 - $4.34
GANX News
GANX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gain Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Gene C. Mack, MBA
Website
www.gaintherapeutics.comHeadquarters
Bethesda, MD 20814, US
GANX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-156%
Return on Capital
-96%
Return on Assets
-88%
Earnings Yield
-33.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$70.39M
Shares Outstanding
38.46M
Volume
10.83K
Short Interest
0.00%
Avg. Volume
875.52K
Financials (TTM)
Gross Profit
$94.05K
Operating Income
$18.71M
EBITDA
$18.71M
Operating Cash Flow
$18.47M
Capital Expenditure
$0.00
Free Cash Flow
$18.47M
Cash & ST Invst.
$20.84M
Total Debt
$331.11K
Gain Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.87M
+22975.9%
Gross Margin
0.00%
N/A
Market Cap
$70.39M
N/A
Market Cap/Employee
$3.06M
N/A
Employees
23
N/A
Net Income
$4.54M
-20.4%
EBITDA
$4.47M
-37.7%
Quarterly Fundamentals
Net Cash
$20.51M
+110.7%
Accounts Receivable
$802.69K
+4.8%
Inventory
$0.00
N/A
Long Term Debt
$422.48K
+10.6%
Short Term Debt
$119.88K
-55.8%
Return on Assets
-88.35%
N/A
Return on Invested Capital
-96.12%
N/A
Free Cash Flow
$12.74M
-268.7%
Operating Cash Flow
$12.74M
-268.8%